<SEC-DOCUMENT>0001558370-22-006479-index.html : 20220429 <SEC-HEADER>0001558370-22-006479.hdr.sgml : 20220429 <ACCEPTANCE-DATETIME>20220429160610 ACCESSION NUMBER: 0001558370-22-006479 CONFORMED SUBMISSION TYPE: DEF 14A PUBLIC DOCUMENT COUNT: 4 CONFORMED PERIOD OF REPORT: 20220616 FILED AS OF DATE: 20220429 DATE AS OF CHANGE: 20220429 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TG THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001001316 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 363898269 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEF 14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-32639 FILM NUMBER: 22875188 BUSINESS ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 BUSINESS PHONE: (212) 554-4484 MAIL ADDRESS: STREET 1: 2 GANSEVOORT STREET, 9TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10014 FORMER COMPANY: FORMER CONFORMED NAME: MANHATTAN PHARMACEUTICALS INC DATE OF NAME CHANGE: 20030310 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC TECHNOLOGY VENTURES INC DATE OF NAME CHANGE: 20000330 FORMER COMPANY: FORMER CONFORMED NAME: ATLANTIC PHARMACEUTICALS INC DATE OF NAME CHANGE: 19960703 </SEC-HEADER> <DOCUMENT> <TYPE>DEF 14A <SEQUENCE>1 <FILENAME>tmb-20220616xdef14a.htm <DESCRIPTION>DEF 14A <TEXT> Document 1 - file: tmb-20220616xdef14a.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>2 <FILENAME>tmb-20220616xdef14a015.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 2 - file: tmb-20220616xdef14a015.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>3 <FILENAME>tmb-20220616xdef14a001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 3 - file: tmb-20220616xdef14a001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>tmb-20220616xdef14a016.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: tmb-20220616xdef14a016.jpg
</DOCUMENT> </SEC-DOCUMENT>